| text 
Acatak® (Fluazuron)
Product information on this website is for Non-U.S. residents only and is provided by Novartis Animal Health Inc. for general purposes only. Many veterinary products listed are available upon prescription only, and not all such products may be available in all countries. The product information is not intended to provide complete medical information. SHOULD YOUR ANIMAL HAVE A MEDICAL CONDITION, PROMPTLY SEE YOUR OWN VETERINARIAN. WE DO NOT OFFER PERSONALIZED MEDICAL DIAGNOSIS OR ANIMAL-SPECIFIC TREATMENT ADVICE. You should always obtain complete medical information about your veterinary product prescription (including their beneficial medical uses and possible adverse effects) by discussing the appropriate use of any veterinary product directly with the prescribing veterinarian.
Veterinary professionals may obtain complete medical information from the product's information leaflet. Information on these products may vary by country. Animal owners and veterinarians should check with local medical resources and regulatory authorities for information appropriate to their country. In addition, current regulations in many countries limit (or even prohibit in some instances) the ability of Novartis Animal Health Inc. to provide information and/or to respond directly to questions regarding its prescription products. Novartis Animal Health Inc., however, will respond to inquiries from and provide information to your qualified health care professional in accordance with local regulations.
Description
Product Type
Tick growth regulator for beef cattle
Description and Composition
ACATAK PO 025 is a ready-to-use pour-on formulation containing 25 g of fluazuron per liter
Properties
Fluazuron, the active ingredient of ACATAK, is an acarine growth regulator belonging to the group of benzoyl-phenyl-ureas (BPUs). Like all BPUs, fluazuron interferes with the chitin synthesis. Treated immature ticks are unable to moult to the next stage, and no larvae will hatch from eggs laid by treated females.
Due to its specific mode of action, ACATAK is specially suited for the control of one-host ticks of the genus Boophilus. In situations where cattle serve as unique or major host for immature and adult stages of multihost ticks, the repeated use of ACATAK may also lead to a substantial reduction of the multihost tick population.
Indications
ACATAK is a ready-to-use pour-on formulation for the control of the cattle tick Boophilus spp. In specific situations, it may also help to reduce substantially multi-host tick populations.
Dosage and administration
The recommended dose rate is
- 1.5 mg fluazuron/kg (6 ml of ACATAK /100 kg liveweight) for the control of Boophilus microplus in Australia.
- 2.5 mg fluazuron /kg (10 ml of ACATAK /100 kg liveweight) for the control of Boophilus microplus and B. decoloratus in Latin America and Africa, as well as for use against multihost ticks
Frequency of application will depend on tick species and local conditions. Usually, treatments can be spread 7 to 12 weeks apart.
When used strategically according to label or local guidelines, the number of treatments will be 2 to 4 per year.
Withdrawal periods
Withdrawal periods according to national registrations.
Special Precautions and Warnings
Avoid contact with eyes and skin. In case of accidental skin contamination, wash area immediately with soap and water.
The product is toxic to aquatic invertebrates. Do not contaminate fish ponds, dams and rivers.
Formulations and Packages
ACATAK PO 025
- Squeeze bottle 1lt
- Back-pack 5 lt
- Drum 20 lt (Australia only)
Product Availability
Please note that not all products listed within this site may be available in all countries. Also, prescribing information and indications for products may differ from country to country, so please consult your local veterinarian for local prescribing and any other information you may be interested in.
Locations
Headquartered in Basel, Switzerland, and present in almost 40 countries, Novartis Animal Health employs approximately 2,700 associates worldwide.
Partnerships
Novartis collaborates with many companies and academic institutions to develop new products, acquire platform technologies, and access new markets.